On June 20th, Bridge Point Capital will attend the 2020 Sino-American Pharmaceutical Professionals Association (SAPA)’s Investment Summit and Roadshow. SAPA is one of the most influential North America-based nonprofit organizations in the biotechnology sector, whose members are made up of more than 6000 leading experts with diverse backgrounds, including biomedicine scientists, large pharmaceutical company executives, and industry leaders.
Attendants at the annual conference last year consisted of pharmaceutical conglomerates like Merck, Novartis and Bristol-Myers Squibb, renowned scientists like Martin Chalfie, PhD (2008 Nobel Laureate in Chemistry), senior consultants at FDA, and famous investment institutions, such as AIG and Fosun Capital. Bridge Point Capital’s (BPC) Co-founder Mark Young and investment advisor Chuck Clarvit were invited as keynote speakers for the event.
Due to COVID-19, this year’s investment summit will be held virtually for the first time, but this doesn’t decrease the participants’ enthusiasm. Besides many representatives from pharmaceutical giants, VCs and industry experts, SAPA also invited several promising startups to be a part of the roadshow, making this event a great showcase of North American biomedicine investments in 2020.
Notably, Clerio Vision - a rising star in the vision care space, has been invited to join this annual healthcare investment summit. Clerio’s cornerstone technology is LIRIC (Laser-Induced Refractive Index Change) , which is developed by Donna Strickland, PhD (2018 Nobel Laureate in Physics) from Rochester University. LIRIC technology can be applied to various fields including vision correction surgeries, contact lens and IOLs (Intraocular Lens). Its noninvasiveness, safeness and wide eligibility for patients make it extremely promising for growth. LIRIC may become the most revolutionary technology in the vision correction space for the next 20 years.
SAPA’s 2020 Investment Summit and Roadshow is undoubtedly a win-win situation for both startups and investors. Attendees will be able to acquire and exchange the most updated and exciting news in healthcare investments. Participating investors will be able to share their opinion on investment trends and source investment opportunities.
Bridge Point Capital is a private equity firm based in New York focusing on investment in cross-border healthcare. We are dedicated to discovering and supporting healthcare and life science companies that possess revolutionary technologies that promote human health. By leveraging our team’s experience in and understanding of capital markets and medical industry, we discover and advise the most excellent teams and enterprises, seeking to build a platform that advance the interests of both healthcare companies and investors.